SavedAdd your journal

Journals / Journal of Experimental and Clinical Medicine / 2023 / Cilt: 40 Sayı: 2

The comparison of PAP smear test results of women according to anti mullerian hormone levels

İnci ÖZ
Asena AYAR MADENLİ
Ergül DEMİRÇİVİ
Pages
244–247
Publication Date
2023-07-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In conclusion, the results indicated that the serum AMH level and PAP smear test results had a significant relationship.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: This study aims to investigate the relationship between PAP smear test results and anti mullerian hormone (AMH) levels.
📊
Key Findings & Data:Material and Method: This retrospective cross-sectional study included 104 women of reproductive age who applied for a PAP smear test.
💡
Conclusion & Impact:Conclusion: In conclusion, the results indicated that the serum AMH level and PAP smear test results had a significant relationship.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Cervical cancer · anti mullerian hormone · pap smear test

Abstract

Aim: This study aims to investigate the relationship between PAP smear test results and anti mullerian hormone (AMH) levels. The PAP smear test is used to screen for cervical cancer. This test identifies malignant or pre-malignant cells of the cervix and permits timely diagnosis and treatment. Material and Method: This retrospective cross-sectional study included 104 women of reproductive age who applied for a PAP smear test. This study was conducted between October 2019 and December 2020. Patients were clustered as subjects: 1) with an AMH <1ng/ml 2) with an 13ng/ml. Results: The mean age of the study group was 28.45 ± 3.31 years. There was a statistically significant association between AMH levels and PAP smear test results (p<0.05). AMH>3ng/ml group had a significant relationship with the AGUS PAP smear results. There was a statistically significant association between AMH between 1 and 3 and normal PAP smear test result. Conclusion: In conclusion, the results indicated that the serum AMH level and PAP smear test results had a significant relationship.

🔖

Cite This Article

ÖZ, İ., MADENLİ, A. A., DEMİRÇİVİ, E. (2023). The comparison of PAP smear test results of women according to anti mullerian hormone levels. Journal of Experimental and Clinical Medicine, Cilt: 40 Sayı: 2, 244–247. https://ajindex.com/articles/966379

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021; 71: 209-49
  2. Agadayi E, Karademir D, Karahan S. Knowledge, Attitudes and Behaviors of Women who have or have not had human papillomavirus vaccine in Turkey about the Virus and the vaccine. J Community Health 2022; 47: 650-7
  3. Tanaka S, Palmer M, Katanoda K. Trends in cervical cancer incidence and mortality of young and middle adults in Japan. Cancer Sci 2022; 113: 1801-7
  4. Brisson M, Kim JJ, Canfell K, et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet 2020; 395: 575-90
  5. Marashi T, Irandoost SF, Yoosefi Lebni J, Soofizad G. Exploring the barriers to Pap smear test in Iranian women: a qualitative study. BMC Womens Health 2021; 21: 287
  6. Fallahi A, Taymoori P, Aslibeigi F, Khoshravesh S. The Pap Smear Test Experience of Iranian Women: A Qualitative Study. JECH 2022; 8: 291-7
  7. Yurci A, Gungor N. Low Antimullerian Hormone Levels Improve Fertility Outcome in Patients with Polycystic Ovary Syndrome. Gynecol Reprod Health 2021; 5: 1-5
  8. Rey R, Lukas-Croisier C, Lasala C, Bedecarrás P. AMH/MIS: what we know already about the gene, the protein and its regulation. Mol Cell Endocrinol 2003; 211: 21-31
  9. Bedenk J, Vrtačnik-Bokal E, Virant-Klun I. The role of anti-Müllerian hormone (AMH) in ovarian disease and infertility. J Assist Reprod Genet 2020; 37: 89-100
  10. Güngör ND, Gürbüz T. Prediction of the number of oocytes based on AMH and FSH levels in IVF candidates. J Surg Med 2020; 4: 733-7
  11. Gungor ND, Gurbuz T. Pregnancy Outcomes of Intrauterine Insemination in Age-Matched Young Women According to Serum Anti-Mullerian Hormone Levels. JRM 2021; 66: 195-202
  12. Tal R, Seifer CM, Khanimov M, Seifer DB, Tal O. High serum Antimullerian hormone levels are associated with lower live birth rates in women with polycystic ovarian syndrome undergoing assisted reproductive technology. Reprod Biol Endocrinol 2020; 18: 20
  13. Gürbüz T, Gungor ND, Tanrıdan Okçu N,Alanya Tosun Ş. Correlation Between Antı-Mullerian Hormone Levels And Sexual Dysfunction in Infertile Women. ARJGO 2020; 4: 10-6
  14. Gungor ND, Gurbuz T, Onal M. Comparison of complication rates after transvaginal ultrasound-guided oocyte pick-up procedures with respect to ovarian response.